Vertex Pharmaceuticals Incorporated (VRTX), headquartered in Boston, Massachusetts and founded in 1989, develops, manufactures and commercializes transformative medicines for serious diseases, with a primary focus on cystic fibrosis, sickle…
HQ: Boston, MA, United States of Americawww.vrtx.com
USD515.44+0.17%vs prev. close
Market snapshot
Price
USD515.44
Daily move
+0.17%
P/E
29.9
EPS TTM
17.22
Dividend yield
—
Beta
0.32
Market cap
130.6B
Price history
VRTX price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Vertex Pharmaceuticals
VRTX
Biotechnology
130.6
29.9
—
-5.6%
-2.0%
+15.8%
+9.8%
+29.7%
+13.7%
🔒
Subscribe to Equity Analytics to compare VRTX with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.